Stifel Financial Corp Has $2.09 Million Stock Holdings in Balchem Co. (NASDAQ:BCPC)

Stifel Financial Corp increased its position in Balchem Co. (NASDAQ:BCPC) by 26.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,893 shares of the basic materials company’s stock after purchasing an additional 2,467 shares during the quarter. Stifel Financial Corp’s holdings in Balchem were worth $2,093,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of BCPC. FMR LLC lifted its position in shares of Balchem by 944.3% in the third quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock valued at $87,559,000 after buying an additional 449,854 shares during the last quarter. Victory Capital Management Inc. lifted its holdings in Balchem by 129.7% during the 3rd quarter. Victory Capital Management Inc. now owns 98,853 shares of the basic materials company’s stock valued at $17,398,000 after purchasing an additional 55,822 shares during the last quarter. Congress Asset Management Co. boosted its position in Balchem by 12.4% during the third quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock worth $53,053,000 after purchasing an additional 33,373 shares during the period. Conestoga Capital Advisors LLC increased its holdings in shares of Balchem by 2.7% in the second quarter. Conestoga Capital Advisors LLC now owns 1,155,209 shares of the basic materials company’s stock valued at $177,844,000 after purchasing an additional 29,825 shares during the last quarter. Finally, Fiera Capital Corp bought a new position in shares of Balchem in the third quarter valued at about $4,201,000. Institutional investors own 87.91% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on BCPC. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright boosted their price objective on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th.

Balchem Stock Down 0.0 %

BCPC stock opened at $166.51 on Friday. Balchem Co. has a fifty-two week low of $135.84 and a fifty-two week high of $186.03. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The stock has a market capitalization of $5.41 billion, a price-to-earnings ratio of 44.76, a PEG ratio of 5.32 and a beta of 0.67. The business’s fifty day moving average price is $175.20 and its two-hundred day moving average price is $169.55.

Balchem Increases Dividend

The firm also recently disclosed an annual dividend, which will be paid on Friday, January 17th. Shareholders of record on Thursday, December 26th will be paid a $0.87 dividend. This is a boost from Balchem’s previous annual dividend of $0.79. The ex-dividend date of this dividend is Thursday, December 26th. This represents a yield of 0.4%. Balchem’s payout ratio is 23.39%.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.